J-1063 is a potent, selective, and orally active ALK5 inhibitor with an IC50 value of 0.039 µM; it exhibits anti-hepatic fibrosis effects by inhibiting inflammatory infiltration, collagen deposition, and hepatocyte necrosis; it has potential for the study of hepatic fibrosis.